These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17190960)

  • 21. Rilutek (Riluzole) may extend survival in amyotrophic lateral sclerosis.
    J Neurosci Nurs; 1996 Aug; 28(4):275. PubMed ID: 8880606
    [No Abstract]   [Full Text] [Related]  

  • 22. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis.
    Wicks P; Ganesalingham J; Collin C; Prevett M; Leigh NP; Al-Chalabi A
    Amyotroph Lateral Scler; 2007 Jun; 8(3):177-9. PubMed ID: 17538780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preface: the state of the science of all motor neuron diseases.
    Weiss MD; Carter GT
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):xix-xx. PubMed ID: 18625405
    [No Abstract]   [Full Text] [Related]  

  • 24. Reversible granulocytopenia in association with riluzole therapy.
    North WA; Khan AM; Yamase HT; Sporn JR
    Ann Pharmacother; 2000 Mar; 34(3):322-4. PubMed ID: 10917377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypersensitivity pneumonitis possibly caused by riluzole therapy in ALS.
    Cassiman D; Thomeer M; Verbeken E; Robberecht W
    Neurology; 2003 Oct; 61(8):1150-1. PubMed ID: 14581688
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    Carter GT; Krivickas LS; Weydt P; Weiss MD; Miller RG
    IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole.
    Sívori M; Rodríguez GE; Pascansky D; Sáenz C; Sica RE
    Medicina (B Aires); 2007; 67(4):326-30. PubMed ID: 17891927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival endpoint: pro.
    Bensimon G
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S35-6. PubMed ID: 12396802
    [No Abstract]   [Full Text] [Related]  

  • 29. [Riluzole-induced interstitial pneumonia in a case with amyotrophic lateral sclerosis].
    Takeshima S; Neshige S; Himeno T; Takamatsu K; Shimoe Y; Kuriyama M
    Rinsho Shinkeigaku; 2015; 55(11):840-3. PubMed ID: 26399668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cephalon's unusual NDA move.
    Nat Biotechnol; 1998 Jan; 16(1):8. PubMed ID: 9447581
    [No Abstract]   [Full Text] [Related]  

  • 31. Icteric toxic hepatitis associated with riluzole.
    Castells LI; Gámez J; Cervera C; Guardia J
    Lancet; 1998 Feb; 351(9103):648. PubMed ID: 9500328
    [No Abstract]   [Full Text] [Related]  

  • 32. Riluzole.
    Wokke J
    Lancet; 1996 Sep; 348(9030):795-9. PubMed ID: 8813989
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
    Neurol Sci; 2003 Nov; 24(4):290-2. PubMed ID: 14658053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost effectiveness: summary.
    Ringel SP
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S67-9. PubMed ID: 12396813
    [No Abstract]   [Full Text] [Related]  

  • 35. Limitations of inferences from observational databases in amyotrophic lateral sclerosis: all that glitters is not gold.
    Armon C; Guiloff RJ; Bedlack R
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Sep; 3(3):109-12. PubMed ID: 12495570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What has changed with riluzole?
    Meininger V; Lacomblez L; Salachas F
    J Neurol; 2000 Dec; 247 Suppl 6():VI/19-22. PubMed ID: 19714404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moderately severe acute pancreatitis associated with riluzole.
    Ianiro G; Cammarota G; Milani A; Mettimano M; Gasbarrini A
    J Clin Gastroenterol; 2014 Jul; 48(6):563. PubMed ID: 24356456
    [No Abstract]   [Full Text] [Related]  

  • 38. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
    Dib M
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS.
    Ajroud-Driss S; Saeed M; Khan H; Siddique N; Hung WY; Sufit R; Heller S; Armstrong J; Casey P; Siddique T; Lukas TJ
    Amyotroph Lateral Scler; 2007 Oct; 8(5):305-9. PubMed ID: 17852022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic concepts in Amyotrophic Lateral Sclerosis (ALS)].
    Ludolph AC
    Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S21. PubMed ID: 24242034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.